Hidden Alzheimer’s Signals Seen in Some People With Parkinson’s—Before Memory Problems Appear

A new analysis suggests that some older adults with Parkinson’s may carry early biological signs linked to Alzheimer’s—even when their thinking and memory are still intact. Researchers in Japan looked at Parkinson’s patients without dementia and found that those diagnosed in their 80s were about three times more likely to test “amyloid-positive,” a marker associated with Alzheimer’s disease risk, than people diagnosed at younger ages. The team measured amyloid-beta in spinal fluid, a standard way to look for hidden Alzheimer’s-related changes, and then compared results across age groups. There were two surprising twists. First, even in these older Parkinson’s patients, none had dementia—so the amyloid finding seems to be a very early warning signal rather than proof of cognitive decline. Second, when researchers compared Parkinson’s patients to cognitively normal people of the same age in the general population, the Parkinson’s group actually showed lower overall rates of amyloid buildup. That pattern hints that Parkinson’s may alter how Alzheimer’s biology unfolds—possibly shortening the “silent” phase of amyloid accumulation so that once it appears, the path toward cognitive problems could move faster in a subset of patients. The study also noted age-related shifts in other Alzheimer’s biomarkers, such as tau proteins. Why does this matter? As more people are diagnosed with Parkinson’s later in life, early clues like amyloid status could help doctors decide who might benefit from closer cognitive monitoring or from future treatments aimed at delaying dementia. The researchers’ takeaway is practical: build better screening strategies for older adults with Parkinson’s who don’t yet have memory symptoms, and test whether early, targeted interventions can keep them thinking clearly for longer.